QUOTIENT LTD (QTNT) Stock Price & Overview

NASDAQ:QTNT • JE00BNNSZY03

Current stock price

0.38 USD
+0.01 (+2.73%)
At close:
0.3593 USD
-0.02 (-5.45%)
After Hours:

The current stock price of QTNT is 0.38 USD. Today QTNT is up by 2.73%. In the past month the price decreased by -52.38%. In the past year, price decreased by -99.63%.

QTNT Key Statistics

52-Week Range0.1811 - 104.2
Current QTNT stock price positioned within its 52-week range.
1-Month Range0.1811 - 0.8007
Current QTNT stock price positioned within its 1-month range.
Market Cap
1.291M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-53.21
Dividend Yield
N/A

QTNT Stock Performance

Today
+2.73%
1 Week
+79.08%
1 Month
-52.38%
3 Months
-93.67%
Longer-term
6 Months -96.04%
1 Year -99.63%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

QTNT Stock Chart

QUOTIENT LTD / QTNT Daily stock chart

QTNT Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to QTNT. When comparing the yearly performance of all stocks, QTNT is a bad performer in the overall market: 99.79% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

QTNT Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to QTNT. QTNT has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

QTNT Earnings

Next Earnings DateN/A
Last Earnings DateNov 14, 2022
PeriodQ2 / 2023
EPS Reported-$10.81
Revenue Reported
EPS Surprise -194.39%
Revenue Surprise -21.78%

QTNT Forecast & Estimates

7 analysts have analysed QTNT and the average price target is 61.2 USD. This implies a price increase of 16005.26% is expected in the next year compared to the current price of 0.38.

For the next year, analysts expect an EPS growth of 44.75% and a revenue growth 6.8% for QTNT


Analysts
Analysts85.71
Price Target61.2 (16005.26%)
EPS Next Y44.75%
Revenue Next Year6.8%

QTNT Groups

Sector & Classification

Index Membership

QTNT Financial Highlights

Over the last trailing twelve months QTNT reported a non-GAAP Earnings per Share(EPS) of -53.21. The EPS decreased by -11.79% compared to the year before.


Income Statements
Revenue(TTM)37.63M
Net Income(TTM)-155.53M
Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-0.09%
Sales Q2Q%-6.45%
EPS 1Y (TTM)-11.79%
Revenue 1Y (TTM)1.85%

QTNT Ownership

Ownership
Inst Owners1.2%
Shares3.40M
Float3.16M
Ins Owners71.36%
Short Float %N/A
Short RatioN/A

About QTNT

Company Profile

QTNT logo image Quotient Ltd is a CH-based company operating in Health Care Equipment & Supplies industry. Quotient Limited is a Switzerland-based diagnostics company. The firm focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. The company is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company is engaged in developing MosaiQ, which is its technology platform. The firm develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Additionally The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).

Company Info

IPO: 2014-04-16

QUOTIENT LTD

B1, Business Park Terre Bonne, Route de Crassier 13, Eysins

VAUD 1262 CH

CEO: Manuel O. Mendez

Employees: 450

QTNT Company Website

Phone: 41227169800.0

QUOTIENT LTD / QTNT FAQ

Can you describe the business of QUOTIENT LTD?

Quotient Ltd is a CH-based company operating in Health Care Equipment & Supplies industry. Quotient Limited is a Switzerland-based diagnostics company. The firm focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. The company is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company is engaged in developing MosaiQ, which is its technology platform. The firm develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Additionally The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).


Can you provide the latest stock price for QUOTIENT LTD?

The current stock price of QTNT is 0.38 USD. The price increased by 2.73% in the last trading session.


What is the dividend status of QUOTIENT LTD?

QTNT does not pay a dividend.


How is the ChartMill rating for QUOTIENT LTD?

QTNT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.